+44 (0)20 3910 4640 info@symmetron.net
  • 🗨 We’re hiring!
Symmetron
  • Services
  • Therapeutic areas
  • The Team
  • Careers
  • Contact
Select Page

Tocilizumab in polyarticular juvenile idiopathic arthritis: a cost-utility model for the United Kingdom

by Symmetron | Jan 21, 2019

juvenile idiopathic arthritis   Tocilizumab in polyarticular juvenile idiopathic arthritis: a cost-utility model for the United Kingdom Value in Health. 2013;16(7):A564 Authors Chang S, Sawyer L, Dejonckheere F, van Suijlekom-Smit LW, Anink J, Diamantopoulos A Process...

Cost-utility of tocilizumab in the treatment of systemic juvenile idiopathic arthritis in Finland

by Symmetron | Jan 21, 2019

juvenile idiopathic arthritis   Cost-utility of tocilizumab in the treatment of systemic juvenile idiopathic arthritis in Finland Annals of the Rheumatic Diseases. 2013;71:258-259 Authors Hallinen T, Soini EJ, Diamantopoulos A, Dejonckheere F, Vihervaara V, Hautala A,...

Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation

by Symmetron | Jan 21, 2019

Hypertension   Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation Health Technology Assessment....

Cost-effectiveness analysis of alternative antiviral strategies for the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B in the United Kingdom

by Symmetron | Jan 21, 2019

Hepatitis   Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom Value in Health. 2015;18(6):800-9 Authors Bermingham SL, Hughes R, Fenu E, Sawyer LM, Boxall E,...

The cost-effectiveness of supervised exercise for the treatment of intermittent claudication

by Symmetron | Jan 21, 2019

Peripheral arterial disease   Cost-effectiveness of supervised exercise for the treatment of intermittent claudication European Journal of Vascular and Endovascular Surgery. 2013;46(6):707-14 Authors Bermingham SL, Sparrow K, Mullis R, Fox M, Shearman C, Bradbury A,...
« Older Entries

Recent Comments

    Archives

    Categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Privacy Policy
    © 2019 Symmetron Ltd